12,653
Views
16
CrossRef citations to date
0
Altmetric
Review

Ten years in the making: application of CrossMab technology for the development of therapeutic bispecific antibodies and antibody fusion proteins

, & ORCID Icon
Article: 1967714 | Received 15 Jul 2021, Accepted 10 Aug 2021, Published online: 07 Sep 2021

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.